11. Recursion Pharmaceuticals $60,000,000
Round: Series B
Description: Combining experimental biology and bioinformatics to identify 100 new treatments in 10 years.
Industry: Bioinformatics, Biotechnology, Pharmaceutical
Location: Salt Lake City, Utah
Date of funding: 10/04
Total equity funding: $75,350,000
Page 7 of 17